©The Author(s) 2025.
World J Immunol. Nov 18, 2025; 15(1): 111119
Published online Nov 18, 2025. doi: 10.5411/wji.v15.i1.111119
Published online Nov 18, 2025. doi: 10.5411/wji.v15.i1.111119
Table 1 Baseline characteristics of participants, n (%)/mean ± SD
| Characteristic | Group A (n = 100) | Group B (n = 100) | P value |
| Age (years) | 39.6 ± 12.4 | 38.9 ± 11.8 | 0.74 |
| Female | 58 (58) | 55 (55) | 0.68 |
| Duration of asthma (years) | 7.1 ± 4.3 | 7.3 ± 4.0 | 0.81 |
| Baseline IgE (IU/mL) | 239.1 ± 49.7 | 240.6 ± 52.1 | 0.89 |
| FEV1 (L) | 1.91 ± 0.52 | 1.93 ± 0.49 | 0.84 |
| ACT score | 14.3 ± 2.6 | 14.2 ± 2.4 | 0.92 |
- Citation: Agussalim A, Citrawati C, Adam A. Role of IgE cells in the exacerbation and management of asthma: An experimental study. World J Immunol 2025; 15(1): 111119
- URL: https://www.wjgnet.com/2219-2824/full/v15/i1/111119.htm
- DOI: https://dx.doi.org/10.5411/wji.v15.i1.111119